Coronavirus (COVID-19)
KFF COVID-19 Vaccine Monitor: Rural America
12 Months of Trauma: More Than 3,600 US Health Workers Died in Covid’s First Year
Latest from Kaiser Health News
State Data and Policy Actions to Address Coronavirus
There have been over 3 million cases and 131,000 deaths due to COVID-19 in the U.S. Every state and Washington D.C. have eased or lifted at least one social distancing requirement — including 39 states that have eased or lifted stay-at-home orders.
COVID-19 Coronavirus Tracker
This tracker provides the number of cases and deaths from novel coronavirus by country, the trend in case and death counts by country, and a global map of showing which countries have cases and deaths. There have been over 11.8 million confirmed cases and 544,000 confirmed deaths worldwide.
Medicaid Emergency Authority Tracker: Approved State Actions to Address COVID-19
39 states are now addressing the coronavirus emergency with Medicaid/CHIP Disaster Relief State Plan Amendments (SPAs). This tracker also includes details on Section 1135 waivers and 1915 (c) Waiver Appendix K strategies and is regularly updated.
COVID-19 and Related State Data
Use this tool to create custom reports of COVID-19 and related state data. Group COVID-19 cases and deaths with indicators like total hospital beds, health insurance coverage and unemployment claims.
-
Key Questions About COVID-19 Vaccine Mandates
This brief explains the legal basis for vaccine mandates by the federal government, states, and private employers; highlights considerations for mandates while the COVID-19 vaccine is under an EUA; and discusses mandate exemptions based on disability or religious objection.
-
Are Health Centers Facilitating Equitable Access to COVID-19 Vaccinations?
This brief provides greater insight into how states are addressing equity through vaccine allocation and distribution strategies, outreach and communications efforts, and data collection and reporting.
-
How are States Addressing Racial Equity in COVID-19 Vaccine Efforts?
This brief reviews information available through state websites and publicly available vaccine distribution plans to provide greater insight into how states are addressing equity through vaccine allocation and distribution strategies, outreach and communications efforts, and data collection and reporting. It provides a snapshot and examples of state efforts in these areas.
-
A Look at How Medicaid Agencies Are Assisting with the COVID-19 Vaccine Roll-Out
Because Medicaid covers for over 77 million enrollees, including groups disproportionately at risk of contracting COVID-19 as well as hard-to-reach groups, Medicaid agencies can be important partners for the public health agencies that are typically leading the state COVID-19 vaccination efforts. This brief provides insights regarding how state Medicaid agencies are assisting with the COVID-19 vaccine roll-out including specific actions taken.
COVID-19 Vaccination among American Indian and Alaska Native People
This brief presents available data on COVID-19 vaccinations among AIAN people from federal and state sources and discusses factors contributing to success in these vaccination efforts.
The Health Center COVID-19 Vaccination Program is Prioritizing Hard-to-Reach Communities
As part of the Biden administration’s plans to facilitate more equitable access to vaccinations, the administration has formed a partnership with community health centers, known for providing health care to some of the hardest-to-reach populations. This Policy Watch post examines the initial group of health centers to participate early in the Health Center Vaccination Program and the patient populations they serve.
One Year into the Pandemic: Implications of COVID-19 for Social Determinants of Health
This brief provides an overview of social determinants of health and a look at how adults are faring across an array of measures one year into the pandemic.
At-Home SARS-CoV-2 Testing: What Are the Options?
This interactive table includes vendors selling at-home SARS-CoV-2 diagnostic tests that have received emergency use authorization (EUA) from the Food and Drug Administration (FDA).
Five Things to Know about the Cost of COVID-19 Testing and Treatment
This brief answer key questions on affordability of COVID-19 testing and treatment for people who are uninsured and those insured through private coverage, Medicare, and Medicaid.
FAQs on Medicare Coverage and Costs Related to COVID-19 Testing and Treatment
These FAQs provide the latest guidance on testing and treatment related to COVID-19 for Medicare beneficiaries.
COVID-19 Test Prices and Payment Policy
This analysis examines list prices for COVID-19 testing at the largest hospitals in every state and finds they range widely from $20 to $850. Federal law now requires private insurers to cover COVID-19 tests at no cost to the patient and provides funding for people without health insurance.